Fariba Danesh

CIK 1228855 · Director · last filed 2026-10-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$37.75M

Companies

Total Filings

Lifetime Open-Market Net

-$2.75M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

AEHR price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Related Filers

FINISAR CORP — 2 joint filings, latest 2004-06-14

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CRDO	Director	8,239	$172.81	$1.42M	-$260.0K	5	2026-10-14
AEHR	Director	21,509	$63.33	$1.36M	-$1.96M	15	2026-07-02
AVGO	SVP & GM,Fiber Opt. Prod. Div.	104,510	$334.59	$34.97M	-$537.7K	3	2009-08-20

Recent Filings · Page 3 of 3

30 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-07-12	AEHR	Grant (A)	+5,000	$0	EDGAR
2023-01-18	AEHR	Sell (S)	−2,330	-$69.9K	EDGAR
2022-10-21	AEHR	Sell (S)	−2,325	-$46.5K	EDGAR
2022-10-19	AEHR	Grant (A)	+7,162	$0	EDGAR
2022-10-11	AEHR	Sell (S)	−1,550	-$25.0K	EDGAR
2021-10-20	AEHR	Grant (A)	+2,015	$0	EDGAR
2021-07-14	AEHR	Grant (A)	+4,693	$0	EDGAR
2009-08-20	AVGO	Sell (S)	−8,268	-$124.0K	EDGAR
2009-08-12	AVGO	Sell (S)	−27,577	-$413.7K	EDGAR
2009-08-07	AVGO	Grant (A)	—	$0	EDGAR

Showing 21–30 of 30

Prev Page 3 of 3

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.